National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Australia.
J Atten Disord. 2025 Jan;29(2):120-127. doi: 10.1177/10870547241288351. Epub 2024 Oct 8.
The shortage of prescription stimulants is an ongoing issue that is impacting the ability of individuals with ADHD to access their medication. Amidst concerns that this shortage may have a substantial impact on individuals' ability to manage their symptoms effectively, this research seeks to understand the experiences and consequences for those affected.
In this study, we interviewed individuals with ADHD who have been directly impacted by the stimulant shortage. Thematic analysis focused on identifying common themes related to challenges with medication access and the resulting effects on daily living.
The study uncovered significant difficulties in accessing ADHD medication due to current shortages, leading to disruptions in the management of ADHD symptoms and subsequent detriments to individuals' professional, educational, and personal lives. Systematic controls aimed at reducing non-medical use were found to exacerbate these access issues, inadvertently compounding the challenges faced by those using medication for legitimate medical needs. Individuals also described ways they coped with the shortage, with some seeking ADHD medication via unofficial channels.
Our findings highlight the urgency of addressing stimulant shortages to safeguard the wellbeing of individuals with ADHD. This study also calls for a critical review of policy measures regulating stimulant medication access, and their effectiveness at reducing non-medical use given the unintended consequences these regulations appear to have on individuals prescribed these medications for therapeutic purposes.
处方兴奋剂短缺是一个持续存在的问题,影响着 ADHD 患者获得药物的能力。由于担心这种短缺可能会对个人有效管理症状的能力产生重大影响,因此这项研究旨在了解受影响者的经历和后果。
在这项研究中,我们采访了直接受到兴奋剂短缺影响的 ADHD 患者。主题分析侧重于确定与药物获取挑战和对日常生活的影响相关的常见主题。
研究发现,由于目前的短缺,获得 ADHD 药物存在重大困难,导致 ADHD 症状管理中断,随后对个人的职业、教育和个人生活造成损害。旨在减少非医疗用途的系统控制被发现加剧了这些获取问题,无意中加剧了那些出于合法医疗需求而使用药物的人的挑战。参与者还描述了他们应对短缺的方法,一些人通过非官方渠道寻求 ADHD 药物。
我们的研究结果强调了解决兴奋剂短缺问题以保障 ADHD 患者福祉的紧迫性。这项研究还呼吁对管理兴奋剂药物获取的政策措施进行批判性审查,并评估其在减少非医疗用途方面的有效性,因为这些法规似乎对出于治疗目的而开此类药物的个人产生了意外的后果。